Περίληψη:
Purpose To evaluate the potential opportunities and possible
competitiveness of Avatera robotic system (ARS) (Avateramedical,
Germany), and perform predictive cost-analysis for its implementation
and dissemination. Material and methods Our study employed a projective
quantitative research design. SWOT (strengths, weaknesses,
opportunities, threats) analysis was used to map ARS internal
competencies towards external contexts, and potential opportunities and
risks in the robotic market. The ARS purchase and procedural costs were
evaluated in two different scenarios. Results In the first scenario,
setting the purchase cost of the Avatera at around $1.3-1.5 million, a
total $400 procedural cost reduction compared to the RAS performed with
the da Vinci Xi can be calculated. In the second scenario, with a
purchase cos of the ARS of $700.000-800.000 and considering a 5-year
period with an annual ARS volume of 500 procedures, only an additional
$300 will be attributed to the robot itself. Our projections revealed
that for an effective competition the purchase cost of ARS should range
between $700.000 and $800.000 during the initial phase of market
entry. The marketing strategy of the ARS should be oriented towards
countries without any robotic system in operational use, followed by
countries where the competition intensity in the marketplace is low.
Conclusion The introduction of new robotic systems will greatly affect
and reshape the market of robotic surgery. The ARS has all the technical
capacity ensuring the performance of high-quality surgical procedures. A
fast spread and implementation of the ARS could be expected should the
purchase and maintenance costs be kept low.
Συγγραφείς:
Liatsikos, Evangelos
Tsaturyan, Arman
Kyriazis, Iason and
Kallidonis, Panagiotis
Manolopoulos, Dimitris
Magoutas,
Anastasios
